Clinical Trial Update: Explorative Study of AZD1305 in Atrial Fibrillation Patients [Phase 2]

View source ↗

Summary

This document reports the completion and results posting of an exploratory Phase 2 trial of AZD1305 in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• AZD1305

Snippet

Sponsor: AstraZeneca | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2012-01-26